Feedback / Questions
RGLS4326 - Regulus Therapeutics
https://seekingalpha.com/news/3480724-fda-suspends-enrollment-phase-1-study-regulus-rgls4326-shares-25-percent-premarket
Jul 24, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next